AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: aging biologyClear filter
industryEurekAlert!

Insilico Medicine’s Longevity Board Shows the Company Wants to Own Aging Biology, Not Just Drug Discovery

Insilico Medicine has launched what it says is the industry’s first longevity board to accelerate AI-driven aging research. The move reflects a broader push to turn AI platforms into long-horizon biology engines, not just single-program discovery tools.

Insilico Medicinelongevityaging biologydrug discovery
research

Biophytis Uses NVIDIA GTC Stage to Make the Case for AI in Longevity Drug Discovery

Biophytis highlighted AI-driven longevity drug discovery work with LynxKite at NVIDIA GTC 2026, bringing a difficult and often speculative therapeutic area into a more computationally grounded conversation. The story is notable because longevity biotech needs stronger translational credibility, and AI may help tighten the link between complex aging biology and tractable programs.

TipRanks
BiophytislongevityNVIDIA GTC

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.